Literature DB >> 22508147

Chronic gastrointestinal consequences of acute infectious diarrhea: evolving concepts in epidemiology and pathogenesis.

Elena F Verdu1, Mark S Riddle.   

Abstract

Acute infectious diarrhea is a frequent occurrence both in the developing world, where it results in considerable mortality, and in developed countries, where it accounts for a significant number of health visits, hospitalizations, and medical and non-medical losses. Recent evidence in basic, clinical, and epidemiological science domains has emerged that suggest that the burden caused by these infections is not limited to the acute illness, but may result in triggering or contributing to the pathogenesis of a number of chronic health problems. This review considers the breadth of this information for the purpose of consolidating what is currently known, identifying gaps in knowledge, and describing future directions and policy implications related to the chronic consequences of acute infectious diarrhea. A unifying hypothesis of this review is that infections may trigger a number of long-lasting changes in gut physiology and immunity that can increase the risk to a variety of chronic gastrointestinal diseases, particularly in genetically susceptible individuals.

Entities:  

Mesh:

Year:  2012        PMID: 22508147     DOI: 10.1038/ajg.2012.65

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  22 in total

Review 1.  The Traveling Microbiome.

Authors:  Mark S Riddle; Bradley A Connor
Journal:  Curr Infect Dis Rep       Date:  2016-09       Impact factor: 3.725

Review 2.  Traveler's Diarrhea.

Authors:  Stanley L Giddings; A Michal Stevens; Daniel T Leung
Journal:  Med Clin North Am       Date:  2016-03       Impact factor: 5.456

Review 3.  Reconciling Hygiene and Cleanliness: A New Perspective from Human Microbiome.

Authors:  Vipin Gupta; Roshan Kumar; Utkarsh Sood; Nirjara Singhvi
Journal:  Indian J Microbiol       Date:  2019-11-12       Impact factor: 2.461

4.  Postinfectious functional gastrointestinal disorders: a focus on epidemiology and research agendas.

Authors:  Adam Deising; Ramiro L Gutierrez; Chad K Porter; Mark S Riddle
Journal:  Gastroenterol Hepatol (N Y)       Date:  2013-03

5.  Pathogen-specific risk of celiac disease following bacterial causes of foodborne illness: a retrospective cohort study.

Authors:  Mark S Riddle; Joseph A Murray; Brooks D Cash; Mark Pimentel; Chad K Porter
Journal:  Dig Dis Sci       Date:  2013-06-29       Impact factor: 3.199

6.  Murine neonates infected with Yersinia enterocolitica develop rapid and robust proinflammatory responses in intestinal lymphoid tissues.

Authors:  David T Siefker; Andrea Echeverry; Roberta Brambilla; Masayuki Fukata; Kurt Schesser; Becky Adkins
Journal:  Infect Immun       Date:  2013-12-02       Impact factor: 3.441

7.  Antibiotic Therapy for Acute Watery Diarrhea and Dysentery.

Authors:  David R Tribble
Journal:  Mil Med       Date:  2017-09       Impact factor: 1.437

8.  Management of Acute Diarrheal Illness During Deployment: A Deployment Health Guideline and Expert Panel Report.

Authors:  Mark S Riddle; Gregory J Martin; Clinton K Murray; Timothy H Burgess; Patrick Connor; James D Mancuso; Elizabeth R Schnaubelt; Timothy P Ballard; Jamie Fraser; David R Tribble
Journal:  Mil Med       Date:  2017-09       Impact factor: 1.437

9.  The YsrS Paralog DygS Has the Capacity To Activate Expression of the Yersinia enterocolitica Ysa Type III Secretion System.

Authors:  Kimberly A Walker; Lauren A Griggs; Markus Obrist; Addys Bode; R Patrick Summers; Virginia L Miller
Journal:  J Bacteriol       Date:  2016-05-27       Impact factor: 3.490

Review 10.  Guidelines for the prevention and treatment of travelers' diarrhea: a graded expert panel report.

Authors:  Mark S Riddle; Bradley A Connor; Nicholas J Beeching; Herbert L DuPont; Davidson H Hamer; Phyllis Kozarsky; Michael Libman; Robert Steffen; David Taylor; David R Tribble; Jordi Vila; Philipp Zanger; Charles D Ericsson
Journal:  J Travel Med       Date:  2017-04-01       Impact factor: 8.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.